Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2018, Article ID 9368451, 5 pages
https://doi.org/10.1155/2018/9368451
Case Report

Primary Effusion Lymphoma without an Effusion: A Rare Case of Solid Extracavitary Variant of Primary Effusion Lymphoma in an HIV-Positive Patient

1Division of Hematology and Oncology, University of Louisville, Louisville, KY, USA
2Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, USA
3Division of Blood and Marrow Transplant, University of Louisville, Louisville, KY, USA

Correspondence should be addressed to Hamza Hashmi; moc.liamtoh@78imhsahazmah

Received 26 August 2017; Revised 5 December 2017; Accepted 27 December 2017; Published 28 January 2018

Academic Editor: Tatsuharu Ohno

Copyright © 2018 Hamza Hashmi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. F. Little, M. Gutierrez, and E. S. Jaffe, “HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis,” JAMA, vol. 285, no. 14, pp. 1880–1885, 2001. View at Publisher · View at Google Scholar
  2. Y. B. Chen, A. Rahemtullah, and E. Hochberg, “Primary effusion lymphoma,” The Oncologist, vol. 12, no. 5, pp. 569–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-B. Fan, D.-L. Yang, Y. Guo et al., “Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in a patient with hepatitis B virus-related liver cirrhosis: a case report,” Journal of Research in Medical Sciences, vol. 19, no. 2, pp. 190–192, 2014. View at Google Scholar
  4. A. Carbone, A. Gloghini, E. Vaccher et al., “Kaposi’s sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma,” Journal of Molecular Diagnostics (JMD), vol. 7, no. 1, pp. 17–27, 2005. View at Publisher · View at Google Scholar
  5. A. Chadburn, E. Hyjek, S. Mathew, E. Cesarman, J. Said, and D. M. Knowles, “KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma,” American Journal of Surgical Pathology, vol. 28, no. 11, pp. 1401–1416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Guillet, L. Gerard, V. Meignin et al., “Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution,” American Journal of Hematology, vol. 91, no. 2, pp. 233–237, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Boulanger, L. Gerard, J. Gabarre et al., “Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS,” Journal of Clinical Oncology, vol. 23, no. 19, pp. 4372–4380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Berryman, “Primary effusion lymphoma complete remission with HAART (abstract 4741)”.
  9. E. Boulanger, F. Agbalika, O. Maarek et al., “A clinical, molecular and cytogenic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma (abstract 4683),” in Presented at the 42nd Annual American Society of Hematology Meeting, San Francisco, CA, USA, December 2000.
  10. K. Dunleavy and W. H. Wilson, “How I treat HIV-associated lymphoma,” Blood, vol. 119, no. 14, pp. 3245–3255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Ripamonti, B. Marini, A. Rambaldi, and F. Suter, “Treatment of primary effusion lymphoma with highly active antiviral therapy in the setting of HIV infection,” AIDS, vol. 22, no. 10, pp. 1236-1237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. A. Torres and V. Mulanovich, “Management of HIV infection in patients with cancer receiving chemotherapy,” Clinical Infectious Diseases, vol. 59, no. 1, pp. 106–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Okada, H. Goto, and M. Yotsumoto, “Current status of treatment for primary effusion lymphoma,” Intractable and Rare Diseases Research, vol. 3, no. 3, pp. 65–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. A. G. Freifeld, E. J. Bow, K. A. Sepkowitz et al., “Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 52, no. 4, pp. e56–e93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cassoni, U. Ali, J. Cave et al., “Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma,” Journal of Clinical Oncology, vol. 26, no. 32, pp. 5297–5299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. W. Waddington and D. M. Aboulafia, “Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review,” AIDS Patient Care and STDs, vol. 18, no. 2, pp. 67–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Won, S. H. Han, S. B. Bae et al., “Successful eradication of relapsed primary effusion lymphoma with high-dose chemotherapy and autologous stem cell transplantation in a patient seronegative for human immunodeficiency virus,” International Journal of Hematology, vol. 83, no. 4, pp. 328–330, 2006. View at Publisher · View at Google Scholar · View at Scopus